DNA2.0’s innovative bioengineering tools are helping to speed the transformation of biology from a discovery science to an engineering discipline.—Jeremy Minshull, Ph.D., cofounder and CEO of DNA2.0.
Menlo Park, CA (PRWEB) July 31, 2012
DNA2.0, the leading bioengineering solutions provider, today announced its sponsorship of Singularity University’s inaugural synthetic biology accelerator program, the SynBio Startup Launchpad. The program will nurture aspiring life science entrepreneurs seeking to apply the rapid-cycle, low-cost approaches employed by tech and biotech startups.
“DNA2.0’s innovative bioengineering tools are helping to speed the transformation of biology from a discovery science to an engineering discipline,” said Jeremy Minshull, Ph.D., cofounder and CEO of DNA2.0. “As a first-generation synthetic biology startup, we are excited to support Singularity University in helping our nascent industry advance.”
Two companies were selected by SU for the SynBio Program: Evolutionary Solutions and Modern Meadow. Evolutionary Solutions (founders Kettner Griswold and Paul Sebexen) is developing an oligo- to genome-scale synthesis device. Modern Meadow (co-founder Andras Forgacs) applies the latest advances in tissue engineering to produce a range of novel biomaterials for food and textile applications.
The selected entrepreneurs go through four months of comprehensive, customized mentoring and education in bringing their ideas to market. The companies receive close mentorship from a network of experienced advisors, weekly speakers on critical venture topics, networking with their peers, and valuable discounted services to launch their companies.
The first program will conclude in late August with the SynBio Companies pitching their ventures to investors and the community at “demo day” events.
DNA2.0 is the leading bioengineering solutions provider. Founded in 2003, DNA2.0 offers an integrated pipeline of solutions for the research community, including gene design, optimization, synthesis and cloning, as well as platforms for protein and strain engineering. It is the fastest provider of synthetic genes—based in the US with a global customer base encompassing academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. DNA2.0 is by far the most published synthetic gene vendor, providing expert support to and collaboration with scientists. DNA2.0 explores novel applications for synthetic genes and is exploiting the synergy between highly efficient gene design and synthesis processes and new protein optimization technologies. DNA2.0’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline. The company is privately held and is headquartered in Menlo Park, Calif. For more information, please visit http://www.DNA20.com.
About Singularity University
Singularity University’s mission is to assemble, educate, and inspire a new generation of leaders in business, science, finance, and government who strive to understand and use exponentially advancing technologies to address humanity’s grand challenges. Corporate Partners include Autodesk, Cisco, ePlanet Ventures, Genentech, Google, Kauffman Foundation, and Nokia. Since 2009, SU has hosted students and industry leaders from more than 60 countries at its campus at NASA Research Park, Moffett Field, CA.
SU offers a Summer Graduate Studies Program and numerous Executive Programs throughout the year focused on the impact and incubation of exponentially advancing technologies in the key areas of medicine and neuroscience, networks and computing systems, artificial intelligence and robotics, biotechnology and bioinformatics, nanotechnology, space and physical science, and energy and environmental systems. SU programs focus on the intersection of these areas with each other and with policy, law, and ethics; design; entrepreneurship; finance and economics; and futures studies and forecasting. For more information about the SynBio program visit http://www.singularityu.org/synbio